openPR Logo
Press release

Global Thalassemia Market Size – Forecast to 2026

Thalassemia Market Size – Forecast to 2026

Thalassemia Market Size – Forecast to 2026

The findings reviewed by GME stated that the Global Thalassemia Market will expand with a CAGR value of 10.2 percent from 2021 to 2026. Several drivers are likely to accelerate the thalassemia market further, including an increasing occurrence of thalassemia, growing public awareness, expanding expenditure in research & development, and the growing need for improved curative gene therapy.

Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on “Global Thalassemia Market - Forecast to 2026” https://www.globalmarketestimates.com/market-report/global-thalassemia-market-3138

By Therapeutic Class (Iron Chelating Drugs), By Pipeline (Gene Therapy), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis.
Key Market Insights
• An increasing number of patented medicines and targeted therapies for thalassemia treatment would boost the global thalassemia market.
• Iron chelation prevents iron toxicity complications such as heart and hepatic malfunction which makes it a perfect therapeutic class for thalassemia.
• Gene therapy enables successful exvivo genetic alteration of human stem cells, which can result in hemoglobin synthesis and a significant therapeutic advantage in thalassemia patients.
• The increasing number of thalassemia patients in the U.S is expected to propel the North American market forward.
• Acceleron Pharma, Inc., Bluebird Bio, Inc., CRISPR Therapeutics, La Jolla Pharmaceutical Company, Incyte Corporation, IONIS Pharmaceuticals, GlaxoSmithKline plc., Kiadis Pharma, Lonza Group AG, Alnylam Pharmaceuticals Inc, Sangamo Bioscience, Calimmune Inc, Gamida Cell Ltd, Editas Medicine Inc, Pharma Essentia Corp, Gilead Sciences Inc, Merck & Co Inc, Zydus Cadila Healthcare Ltd, Protagonist Therapeutics Inc, and others, are major players of thalassemia market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-thalassemia-market-3138

Therapeutic Class Outlook (Revenue, USD Billion, 2021-2026)
• Iron Chelating Drugs

Pipeline Outlook (Revenue, USD Billion, 2021-2026)
• Gene Therapy

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Thalassemia Market Size – Forecast to 2026 here

News-ID: 2286141 • Views: 199

More Releases from Global Market Estimates Research & Consultants

Global Patient Recovery Chair Market- Forecast to 2026
The findings reviewed by GME stated that the Global Patient Recovery Chair Market is estimated to be valued at USD 6100 million in 2021 and is projected to reach USD 8750 million by 2026 at a CAGR of 7.5 %. Advancements in technology and the production of improved electric recovery chairs that are transportable and can be used in home care environments are likely to support the advancement of the
Global Intraoperative Imaging Market- Forecast to 2026
The findings reviewed by GME stated that the Global Intraoperative Imaging Market is estimated to be valued at USD 1900 million in 2021 and is projected to reach USD 2500 million by 2026 at a CAGR of 5%. A few of the important drivers propelling the advancement of the intraoperative imaging market include technological developments, growing surgical frequency, and improved financing and public-private partnerships. Browse 159 Market Data Tables and 119
Global Industrial Display Market – Forecasts to 2026
As per the research conducted by GME, the Global Industrial Display Market will grow with a CAGR value of 6.4 percent. Factors like the development of high specification devices, improved contrast ratio, high growth of LED-backlit, wide temperature range, new product developments are foreseen to result in the growth of the industrial display market. Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on
Global Concentrated Milk Fat Market– Forecasts to 2026
As per the research conducted by GME, the Global Concentrated Milk Fat Market is estimated to be USD 3.78 billion in 2021 and is projected to reach USD 6.60 billion with CAGR 10.0% from 2021 to 2026. The increased use of concentrated milk fat in the food & beverage sector, owing to its extended shelf life, and convenience of shipping & preservation is driving expansion. These advantages lower total costs,

All 5 Releases


More Releases for Thalassemia

Thalassemia Treatment Market is driven by increase in number of altered thalasse …
Thalassemia Treatment Market - Snapshot The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapy
Alpha Thalassemia Market Import | Export Outlook and Global Foresight 2023
Report Description This report analyzes the alpha thalassemia market by type (hb bart syndrome, hbh disease, silent carrier state, and trait.), by diagnosis (perinatal testing, prenatal testing, and pre-implantation), by treatment, by end user; it also studies the top manufacturers in the market. The alpha thalassemia market is expected to grow at a CAGR of approximately 8.8% during the forecast period 2017-2023. GET SAMPLE REPORT @ https://www.wiseguyreports.com/reports/3365840-alpha-thalassemia-market-research-report-global-forecast-till-2023 The major players in
Analytical insights about Beta Thalassemia Testing Market Provided in Detail
Beta thalassemia can be simplified as a diseased state of blood in which there is reduced hemoglobin production. Hemoglobin is a protein containing iron and is present in Red blood cells and the major function of hemoglobin is to carry oxygen to the body cells throughout the body. Low hemoglobin content in the beta thalassemia patients usually leads to the lack of oxygen in many parts of the body. Due
Thalassemia - Pipeline Review, H2 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H2 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms include fussiness, paleness, frequent infections, failure to thrive, poor appetite and jaundice. Predisposing factors include family history. Treatment includes blood transfusions and bone marrow
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms
Global Thalassemia Market Report: 2016 Edition
Thalassemia is a hereditary blood disorder in which a person’s body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesn’t have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemia